Background. Sepsis is associated with volume de®cit and clotting system activation. Platelet activation in sepsis results in an increased formation of microvesicles, which in turn, have been associated with increased mortality. We hypothesized an effect of different volume replacement solutions on platelet-derived microvesicle formation in septic shock.
Increased microvesicle formation has been associated with a higher mortality in a porcine model of endotoxaemia, 8 and has been related to fatal outcome in patients with activated coagulation. 9 Our study is based on the assumption that the choice of volume replacement therapy may also have an important impact on the coagulation process, as it has been recently demonstrated that the use of crystalloids resulted in an enhancement of coagulation. 10 This might be particularly important in patients with severe sepsis/septic shock who generally present with large¯uid de®cits and therefore need volume replacement therapy. 11 Although it is widely accepted that volume replacement therapy is important for restoration and maintenance of the intravascular volume in order to improve organ perfusion and nutritive microcirculatory¯ow, the type of solution which should be used in the treatment of sepsis remains controversial. 12 Given the lack of data in respect to the effect of different volume replacement solutions on microvesicle formation during sepsis the aim of our study was to investigate the effects of 4 and 8% modi®ed¯uid gelatin, hydroxyethyl starch with a mean molecular weight (MW) of 200 kD and a substitution ratio of 0.5 and Ringer's solution on plateletderived microvesicle formation in a porcine septic shock model.
Methods

Animals
German landrace pigs (n=20) of either gender, mean weight 20.8 (SD 1.8) kg, were used. The study protocol was approved by the University Animal Care Committee as well as the federal authorities for animal research of the Bezirksregierung Hannover, Niedersachsen, Germany and the principles of laboratory animal care were followed. The experiments were performed at the animal laboratory of Hannover Medical School (Germany). Animals were fasted for 24 h with access to water ad libitum.
Anaesthesia
As previously described, 13 animals received a premedication of of Azaperon 5 mg kg ±1 (Stressnylâ, Jansen, Neuss, Germany) intramuscularly. Thereafter a peripheral venous catheter was placed in an ear vein and anaesthesia was induced by intravenous injection of propofol (Disoprivanâ, Zeneca, Plankstadt, Germany) until intubating conditions were achieved. Pigs were orally intubated and placed in the supine position. Anaesthesia was maintained with infusion of thiopentone 5 mg kg ±1 h ±1 (Trapanalâ, Byk Gulden, Konstanz, Germany), and fentanyl 0.01 mg kg ±1 h ±1 (Fentanyl Curamedâ, Curamed, Karlsruhe, Germany). Controlled mode ventilation was chosen to ventilate the animals (Servo 900, Siemens-Elema, Solna, Sweden) with an inspiratory oxygen fraction of 0.4, an inspiratory/ expiratory ratio of 1:2, and a respiratory rate of 16 bpm.
The tidal volume was adjusted to maintain a PCO 2 of 35 to 45 torr (4.6 to 5.9 kPa). The core body temperature was maintained at 37±39°C using an infrared lamp, a circulating water-mattress and warmed solutions.
Surgical procedures
Right jugular vein and right carotid artery, as well as the left femoral artery were surgically exposed. For drug and¯uid administration a central venous catheter was inserted into the superior vena cava, and a balloon-tipped thermodilution pulmonary artery catheter (131F7, Baxter Healthcare, Irvine, CA, USA) was inserted via the right jugular vein. Catheters and infusion systems were not lined with heparin. In all animals a midline laparotomy and cystotomy were performed using standardized sterile surgical techniques. A urinary catheter was placed to drain and determine urine output. An opening of 2 cm was made in the caecum and 1 g kg ±1 body weight of its content was aspirated. The caecotomy was then closed and a sterile catheter positioned intra-abdominally before the abdomen was closed with a suture. The catheter was tunnelled out through the subcutaneous tissue of the lateral¯ank. Following surgical preparation animals were allowed to recover for 120 min before baseline measurements (baseline) were performed. A continuous infusion of Ringer's solution (RS; 10 ml kg ±1 h ±1 i.v.) was given during surgery and the postsurgical period.
To induce sepsis, autologous faeces (1 g kg ±1 ) suspended in 150 ml of warm isotonic NaCl (37°C) was injected through the abdominal catheter.
Monitoring and laboratory measurements
Mean arterial pressure (MAP), central venous pressure (CVP) and pulmonary arterial occlusion pressure (PAOP) were recorded from calibrated pressure transducers (Peter v. Berg, Medizintechnik, Engelharting, Germany). Cardiac output (CO) was determined by thermodilution with a CO computer (Vigilanceâ; Baxter Healthcare, Irvine, CA, USA). Data reported being the mean of three injections of 5 ml ice-cold 5% glucose randomly spread over the respiratory cycle. Arterial and mixed venous blood was sampled in heparinized syringes and immediately analyzed (System 860 including co-oximetry system 835, Bayer Diagnostics, Fernwald, Germany) to determine blood gases, pH, PCO 2 , PO 2 , and the calculated variables base excess, standard bicarbonate, and oxygen saturation. This also allowed calculation of systemic oxygen delivery (DO 2 ) and oxygen consumption (VO 2 ) from haemoglobin, oxygen saturation, PO 2 and CO according to standard formulae.
Haematocrit (Hct) and platelet count were determined using an automatic cell counter. Cumulative¯uid balance was calculated as¯uid input minus urinary output over the observation period (8 h).
Volume replacement induced platelet activation in sepsis
Experimental procedure
According to a prede®ned random list, ®ve animals in each group were allocated for¯uid therapy with 4% modi®ed uid gelatin (MFG4%) (Gelafundin, B Braun, Melsungen, Germany) or 8% modi®ed¯uid gelatin (MFG8%) (Braun Medical AG, St Gallen, Switzerland), 6% hydroxyethyl starch (HES) (MW 200 kD/0.5 degree of substitution, Hemohes, B Braun, Melsungen, Germany), and Ringer's solution (DAB 7, B Braun, Melsungen, Germany). The pH of the Ringer's solution used varies between 5.0 and 7.0 (manufacturer's information). In our study we did not check individual bag pH values. Haemodynamic treatment scheme was aimed at maintenance of CVP of 12 mm Hg. After induction of sepsis, animals were observed for 8 h. All variables and blood samples were measured simultaneously before induction of sepsis (baseline) and 8 h after induction. Blood samples for determination of microvesicles were collected in 1.4 ml sodium citrate tubes (No. 06.1668.001, Sarstedt, Nuembrecht, Germany).
Measurement of plasma volume and albumin escape rate
For measurement of the red blood cell volume (RBV) 10 ml of blood was withdrawn and erythrocytes in the plasma-free suspension were labelled with chromium-51-tagged erythrocytes (51Cr) (Berthold MAG 312, Germany). After central venous reinjection of the labelled erythrocytes, arterial blood samples (2 ml) were taken after 30, 45, 240 and 480 min. RBV was calculated from the radioactivity of the isotope before injection and after distribution in the blood: RBV=Total 51Cr activity injectedQHaematocrit (Hct)Qf/Blood 51Cr activity of the sampleQ100. Concentration with f=correction factor (0.91) for whole body Hct. Plasma volume (PV) was determined using a standard formula: PV=(100±Hct)QfQRBV/HctQf.
Preparation of samples for¯ow cytometry
Platelet-rich plasma (5 ml) was added to polystyrene tubes containing 30 ml HEPES-diluted anti-platelet antibody (mouse-anti-pig, DH Sachs, Charlestown, PA, USA). The samples were incubated for 20 min at room temperature. After washing with HEPES-buffer the second¯uorescent antibody (goat-anti-mouse-Phycoerythrin, DAKO, Denmark) was added and incubated for 15 min at room temperature. Again the samples were washed with HEPES and then diluted and ®xed with 500 ml ice-cold PBS, containing 1% p-formaldehyde. Flow cytometry-analysis was performed within 1 h of sampling.
Flow cytometry
Porcine platelets were analyzed using an Epics XLâ cytometer (Beckman Coulter, Krefeld, Germany). Data processing from 20 000 platelets was carried out using WinMDI software. 14 The cytometer gives information related to mean cell size (forward scatter), complexity (side scatter) and percentage of positive antibody-stained cells based on their light-scattering properties. Each single cell is represented by a point in a coordinate system. Analytical markers were set in the¯uorescence channel to divide a negative control sample into fractions containing 97±99% of platelets and 1±3% of the smallest platelets. Platelets with forward scatter lower than the marker were identi®ed as microvesicles. All measurements were run in duplicate. Microvesicles were counted as a percentage of the platelets smaller than a predetermined size in forward scatter in¯ow cytometry. 7 
Statistical analysis
Data were analysed using SPSS for Windows (release 10.07) and all results are presented as mean (SD). After verifying normal distribution (skewness <1.5), 15 ®rst a multivariate analysis of variance for repeated measurements using Wilks±Lambda 16 was performed, followed by a multiple test strategy of Ryan±Einot±Gabriel±Welsh F-test 17 for pairwise intergroup comparison. Differences within groups were compared by two-tailed Student's t-test for paired samples. In order to test the formation of microvesicles and platelets, count baseline values were set as 100% and differences to baseline were calculated.
A P-value <0.05 was considered statistically signi®cant. For this signi®cance level of a=0.05 an analysis for the prospective power of the experimental design was performed for a 2-sided test. A 50% difference in means of the microvesicle formation between two groups was regarded as clinically important. To achieve a power level of 90% ®ve animals in each group were needed.
Results
Systemic haemodynamic parameters following the induction of sepsis are summarized in Table 1 . Baseline values were comparable in all groups. During sepsis there was a signi®cant decrease in MAP and CO in all groups. Eight hours after induction of sepsis, CO was higher in the HEStreated group when compared with MFG4%, MFG8% and RS groups (Table 1) . To maintain a CVP of 12 mm Hg, cumulative¯uid balance in the RS group was signi®cantly higher compared to HES and MFG4% and MFG8% (Table 2) . Compared to baseline, PV was signi®cantly reduced in the RS group. PV could be maintained by HES, MFG4% and MFG8% (Table 2 ). Compared to baseline the platelet count was signi®cantly reduced in HES group with no differences between the groups 8 h after induction of sepsis (Fig. 1) . Compared to baseline, microvesicle formation in the MFG8% group was signi®cantly reduced 8 h after induction of sepsis (Fig. 2) . The formation of microvesicles was signi®cantly increased 8 h after induction of sepsis in the RS group when compared to MFG4%, MFG8% and HES treated animals (Fig. 2) .
Discussion
The most important ®nding of our study was a signi®cant increase in the formation of platelet-derived microvesicles in animals treated with Ringer's solution compared to treatment with arti®cial colloids HES, MFG4% and MFG 8% in a porcine model of septic shock.
Compared to baseline there was a reduction in the platelet count in RS, MFG8%, HES group, which was signi®cant in the latter. The increase in the MFG4% group is due to one animal, which had a very low baseline platelet count, which increased to sub-normal values at the end of the study period. In our study the platelet count did not differ between the groups 8 h after induction of sepsis. Thus, our results con®rm the ®ndings of Larsson and colleagues who support the view that microvesicle formation is not a simple re¯ection of a decrease in platelet count. 7 Similar to our results, increased formation of plateletderived microvesicles has been reported in human gramnegative septic shock and experimental porcine sepsis. During clinical sepsis the activation of platelets and the coagulation system is well known. 18 Recently, it has been suggested that activation of platelets and monocytes as well as adhesion of platelets to neutrophils may play a role in the development of organ dysfunction. 19 In our model, we observed that the massive¯uid input in the Ringer's solution group comprising a total¯uid volume Volume replacement induced platelet activation in sepsis of 11.5 (3.6) litre (576 (183) ml kg ±1 ), and a positive¯uid balance after 8 h of 7.3 (1.0) litre (366 (49) ml kg ±1 ) was associated with a reduced plasma volume. In contrast, restoration of adequate intravascular volume was obtained in the colloid groups. This was combined with a metabolic acidosis and signi®cant lower VO 2 in the RS group compared to the colloid groups. This may indicate circulatory alterations and sequestration occurring in the RS group, thereby reducing functional capacity of vital organs and contributing further to an activation of the coagulation cascade. RS may increase tissue oedema compared to the colloids used. One effect of such an oedema would be to retard oxygen uptake by increasing the distance from blood vessels to the mitochondria; this in turn could reduce functional capacity and contribute to the development of coagulopathy and multiple organ failure. 20 The composition of the different solutions may also be important. Recently, it has been shown that a crystalloid solution in which lactate was substituted by ethyl pyruvate ameliorated intestinal hyperpermeability in rats. 21 Pyruvate probably serves as an endogenous scavenger of ROS, which have been implicated in the pathogenesis of coagulopathy and sepsis. In a murine model of lethal endotoxaemia, treatment with a Ringer's ethyl pyruvate solution in place of a Ringer's lactated solution prolonged survival and blunted the release of interleukin-6. 22 According to our results, Ruttmann and colleagues 23 could demonstrate enhanced coagulation measured by TEG with a volume load of about 1000 ml h ±1 for 3 h. The underlying reasons for the enhanced activation of platelets using crystalloid Ringer's solution remains speculative. It has been discussed that a direct endotoxin effect may cause the increased formation of platelet-derived microvesicles. 7 Another explanation is that the release of platelet-derived microvesicles could be mediated by complement activation. 24 Furthermore, platelet-derived microparticles formed during complement activation in vivo could provide a membrane surface that facilitates the assembly and dissemination of procoagulant enzyme complexes. In this respect, platelet-derived microvesicles might have a potential role in the pathogenesis of disseminated intravascular coagulation. 24 Interestingly, we demonstrated previously, that the complement system is activated in our porcine septic shock model. 25 Another interesting aspect may be the in¯uence of crystalloids on coagulation. In vitro haemodilution with saline 26 or other crystalloid solutions 27 exerted a procoagulant effect, possibly by enhancement of thrombin formation. Recent clinical work demonstrated that haemodilution of up to 30% with saline can induce a hypercoagulable state. 10 This increase in coagulation seems to be independent of the type of crystalloid used. 28 The reduction in antithrombin caused by dilution has been postulated as a possible important mechanism for the enhancement of haemodilution-induced coagulation. 29 In contrast, Innerhofer and colleagues, investigating primary platelet-mediated haemostasis and clot formation, demonstrated that perioperative administration of 6% HES 200/0.5 or MFG4% interfered more with ®brin polymerization and resulting total clot strength than did RS. 30 There may be clinical implications in measuring the production of microvesicles: in order to elucidate the effects of different¯uid types, appropriate study endpoints need to be developed, as mortality does not seem to be a useful endpoint for¯uid resuscitation. Since activation of coagulation occurs in septic shock, measuring the formation of platelet-derived microvesicles might possibly be used as a guide towards therapy.
In conclusion, in a porcine model of septic shock we have shown that the formation of platelet-derived microvesicles was signi®cantly increased in animals treated with Ringer's solution, but not in animals treated with arti®cial colloids HES, MFG4% and MFG 8%. These results suggest that the intravascular activation of platelets in experimental sepsis may be enhanced by crystalloids. 
